Antimicrobials Working Group

@AWG_News

Dedicated to improving the regulatory, investment and commercial environment for emerging antimicrobials and diagnostics companies.

Vrijeme pridruživanja: siječanj 2013.

Tweetovi

Blokirali ste korisnika/cu @AWG_News

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AWG_News

  1. Prikvačeni tweet

    AWG greatly appreciates 's special attention to measures that support innovation in the recently released Inpatient Prospective Payment System () FY 2020 final rule. 1/7

    Prikaži ovu nit
    Poništi
  2. New are crucial to help fight , but current market conditions are forcing the companies trying to develop new drugs out of business. New policies are desperately needed. Learn more from 's :

    Poništi
  3. 4. velj

    . to Present at the 2020 BIO CEO & Investor Conference:

    Poništi
  4. 3. velj

    The antimicrobial market is broken. Legislative changes like the are needed to support the small developers that we depend on for antimicrobial innovation.

    Poništi
  5. 31. sij

    The Benchmark Report shows that, despite some progress, R&D has not increased enough to radically impact the problem of AMR. New legislation and regulations are needed to address the broken market and spur new life saving development

    Poništi
  6. 30. sij

    . President & CEO Manos Perros, CEO Ted Schroeder, and Chief Executive Director Glyn Edwards discuss issues with the current market and potential solutions to spur antimicrobial innovation with :

    Poništi
  7. 29. sij

    . CEO, Ted Schroeder comments on the critical need to improve the market for developers. For the full story in visit:

    Poništi
  8. 29. sij

    Immediate action is needed to help the companies working to fight . Learn how legislation like the can help stabilize the antimicrobial market and spur the development of life-saving treatments:

    Poništi
  9. 28. sij

    Antimicrobial development plays a vital role in modern medicine and protecting public health. It is imperative we invest in antimicrobial innovation to ensure we have a robust pipeline to combat drug-resistance and infectious disease outbreaks.

    Prikaži ovu nit
    Poništi
  10. 28. sij

    BARDA’s commitment to supporting small biotech innovators and investing in antimicrobial development is critical to combating drug-resistance and protecting Americans from infectious disease outbreaks.

    Prikaži ovu nit
    Poništi
  11. 28. sij

    The DISARM Act, bipartisan policy already introduced in the House and Senate, would be a significant step towards stabilizing the fragile antimicrobial market and providing a much-needed incentive to help innovators ensure appropriate patient access.

    Prikaži ovu nit
    Poništi
  12. 28. sij

    Sen. Elizabeth Warren () today announced her plan for Combating Infectious Disease Outbreaks including incentivizing investment in the development for antimicrobials, for which the market is broken, and ongoing support from BARDA.

    Prikaži ovu nit
    Poništi
  13. 27. sij

    Current issues with the marketplace are forcing companies to file for bankruptcy, exacerbating the threat of . Learn more from :

    Poništi
  14. 24. sij

    The lack of investment in innovation is hindering the global fight. 's new report highlights an inadequate antimicrobial pipeline, suggesting market changes are needed.

    Poništi
  15. 23. sij

    . has expanded its award for the clinical and regulatory development of ’s precision ridinilazole for the treatment of infection. The additional funding will support a new clinical trial in adolescent patients:

    Poništi
  16. 23. sij

    is evolving faster than new development. It is critical that policy makers fix the broken market. Learn more about the rising threat of and how legislation like the that has potential to help

    Poništi
  17. 23. sij

    . Announces Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work:

    Poništi
  18. 20. sij

    Recognized as an urgent threat by , invasive infections kill one out of every three patients. highlights the dangers of this and the rising threat of :

    Poništi
  19. 17. sij

    Without new action, the threat of will only grow. shares 5 priorities to combat AMR in 2020, including the use of economic incentives and passing the to catalyze the development of new life-saving :

    Poništi
  20. 16. sij

    New policies such as the and novel financial incentives are critical to creating a robust pipeline to fight infections and protect American lives.

    Prikaži ovu nit
    Poništi
  21. 16. sij

    Antimicrobials play an immensely important role in both modern medicine and national security, yet the pipeline of new antimicrobials is extremely fragile. Learn more: via

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·